Our findings indicate that higher CSF cortisol levels are involved in the pathophysiology of AD, and are related in particular to neuronal injury and tau pathology, as indicated by CSF tau and p-tau levels, and decreased regional brain volumes. This evidence concerns the gene MAPT and Alzheimer disease.